The results showed that the method of radiotherapy plus chemotherapy increase-sensitivity could improve therapeutic effect of esophageal cancer.
2
结论术前新辅助化疗可提高食管癌手术的切除率并不增加术后并发症。
Conclusion Patients of esophageal carcinoma, neoadjuvant chemotherapy can increased the resectability rate, meanwhile cannot increase postoperative complications and mortality.
3
目的：不能手术的食管癌同步放化疗的疗效观察。
Objective: To study the clinical effect of concurrent chemoradiotherapy in patients with inoperable esophageal cancer.
点击反馈